Normal car☐ylation of circulating osteocalcin (bone Gla-protein) in Paget's disease of bone
- 1 November 1990
- journal article
- research article
- Published by Elsevier in Bone and Mineral
- Vol. 11 (2), 237-245
- https://doi.org/10.1016/0169-6009(90)90062-k
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Beneficial effects of aminohexane diphosphonate in patients with paget's disease of bone resistant to sodium etidronateAmerican Journal Of Medicine, 1987
- Serum Osteocalcin In Paget's Disease of Bone: Basal Concentrations and Response to Bisphosphonate TreatmentJournal of Clinical Endocrinology & Metabolism, 1987
- Impaired Carboxylation of Osteocalcin in Warfarin-Treated PatientsJournal of Clinical Endocrinology & Metabolism, 1987
- Serum bone gamma carboxyglutamic acid-containing protein in primary hyperparathyroidism and in malignant hypercalcemia. Comparison with bone histomorphometry.Journal of Clinical Investigation, 1986
- Serum Osteocalcin Concentrations in Paget's Disease of BoneArchives of Internal Medicine, 1986
- Serum bone GLA-protein is not a sensitive marker of bone turnover in Paget's disease of boneCalcified Tissue International, 1986
- SERUM BONE GLA-PROTEIN: A SPECIFIC MARKER FOR BONE FORMATION IN POSTMENOPAUSAL OSTEOPOROSISThe Lancet, 1984
- Urinaryγ-Carboxyglutamic Acid and Serum Osteocalcin as Bone Markers: Studies in Osteoporosis and Paget’s Disease*Journal of Clinical Endocrinology & Metabolism, 1983
- New biochemical marker for bone metabolism. Measurement by radioimmunoassay of bone GLA protein in the plasma of normal subjects and patients with bone disease.Journal of Clinical Investigation, 1980
- Bone histomorphometry in pacet's disease quantitative and dynamic analysis of pagetic and nonpagetic bone tissueArthritis & Rheumatism, 1980